Covid-19 with chemoradiotherapy for esophageal cancer. Clinical case

Abstract

In a pandemic of a new coronovirus infection, patients with malignant neoplasms fall into a special risk group. A clinical case of COVID-19 infection in a patient receiving chemoradiotherapy is presented. The patient received chemoradiotherapy for esophageal cancer and was suspended due to the development of leukopenia. On the 2nd day after discharge from the hospital, the patient developed symptoms of SARS. According to computed tomography signs of viral pneumonia, according to PCR smear revealed RNA of coronavirus SARS (SARS-CoV-2). The patient underwent antiviral, anticoagulant, antibacterial therapy, hematopoietic stimulants, glucocorticosteroids, and immunosuppressant. Conducted CT control in dynamics. On day 14, an improvement was noted, normalization of body temperature, according to CT data on day 14, the volume of lung damage decreased from 45% to 10%, smears on RARS coronavirus RNA (SARS-CoV-2) on 5.10, 14 days after hospitalization were negative. On the 18th day, the patient was discharged with recovery under the supervision of a therapist and continued antitumor treatment. A clinical case demonstrates a successful recovery from COVID-19 against the background of chemoradiotherapy for esophageal cancer complicated by lymphopenia and leukopenia.